Cargando…
Targeting the nitric oxide/cGMP signaling pathway to treat chronic pain
Nitric oxide (NO)/cyclic guanosine 3′,5′-monophosphate (cGMP) signaling has been shown to act as a mediator involved in pain transmission and processing. In this review, we summarize and discuss the mechanisms of the NO/cGMP signaling pathway involved in chronic pain, including neuropathic pain, bon...
Autores principales: | Li, Dan-Yang, Gao, Shao-Jie, Sun, Jia, Zhang, Long-Qing, Wu, Jia-Yi, Song, Fan-He, Liu, Dai-Qiang, Zhou, Ya-Qun, Mei, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9827765/ https://www.ncbi.nlm.nih.gov/pubmed/36254980 http://dx.doi.org/10.4103/1673-5374.355748 |
Ejemplares similares
-
Extracellular cGMP Modulates Learning Biphasically by Modulating Glycine Receptors, CaMKII and Glutamate-Nitric Oxide-cGMP Pathway
por: Cabrera-Pastor, Andrea, et al.
Publicado: (2016) -
cGMP-independent nitric oxide signaling and regulation of the cell cycle
por: Cui, Xiaolin, et al.
Publicado: (2005) -
Targeting L-arginine-nitric oxide-cGMP pathway in pulmonary arterial hypertension
por: Tang, Haiyang, et al.
Publicado: (2017) -
Nitric Oxide–cGMP Pathway Modulation in an Experimental Model of Hypoxic Pulmonary Hypertension
por: Reinero, Melanie, et al.
Publicado: (2021) -
Mechanisms of Activity-dependent Plasticity in Cellular Nitric Oxide-cGMP Signaling
por: Halvey, Edward J., et al.
Publicado: (2009)